Head of Hemoglobinopathy Center
Amsterdam UMC, University of Amsterdam
Amsterdam, Noord-Holland, Netherlands
Disclosure information not submitted.
Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD
Saturday, June 8, 2024
9:00 AM – 9:15 AM ET
Over 4 Years of Safety and Efficacy With Voxelotor in Patients with Sickle Cell Disease
Sunday, June 9, 2024
1:33 PM – 1:51 PM ET